Contribution of ADAM17 and related ADAMs in cardiovascular diseases
- 11 February 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cellular and Molecular Life Sciences
- Vol. 78 (9), 4161-4187
- https://doi.org/10.1007/s00018-021-03779-w
Abstract
A disintegrin and metalloproteases (ADAMs) are key mediators of cell signaling by ectodomain shedding of various growth factors, cytokines, receptors and adhesion molecules at the cellular membrane. ADAMs regulate cell proliferation, cell growth, inflammation, and other regular cellular processes. ADAM17, the most extensively studied ADAM family member, is also known as tumor necrosis factor (TNF)-α converting enzyme (TACE). ADAMs-mediated shedding of cytokines such as TNF-α orchestrates immune system or inflammatory cascades and ADAMs-mediated shedding of growth factors causes cell growth or proliferation by transactivation of the growth factor receptors including epidermal growth factor receptor. Therefore, increased ADAMs-mediated shedding can induce inflammation, tissue remodeling and dysfunction associated with various cardiovascular diseases such as hypertension and atherosclerosis, and ADAMs can be a potential therapeutic target in these diseases. In this review, we focus on the role of ADAMs in cardiovascular pathophysiology and cardiovascular diseases. The main aim of this review is to stimulate new interest in this area by highlighting remarkable evidence.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (HL128324)
- NIDDK (DK111042)
This publication has 336 references indexed in Scilit:
- Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin IIJournal of Molecular and Cellular Cardiology, 2011
- Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17Nature Communications, 2011
- ADAM17 (TACE) regulates TGFβ signaling through the cleavage of vasorinOncogene, 2010
- Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortalityThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in miceJournal of Molecular Medicine, 2010
- ADAM-17 regulates endothelial cell morphology, proliferation, and in vitro angiogenesisBiochemical and Biophysical Research Communications, 2009
- mGluR1/5-Dependent Long-Term Depression Requires the Regulated Ectodomain Cleavage of Neuronal Pentraxin NPR by TACENeuron, 2008
- Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injuryProceedings of the National Academy of Sciences of the United States of America, 2007
- Metalloproteases regulate T-cell proliferation and effector function via LAG-3The EMBO Journal, 2007
- VEGF receptor signalling ? in control of vascular functionNature Reviews Molecular Cell Biology, 2006